The company says doctors will be able to use the software to access best practices. Hospitals can use this new tool to access analytics and to understand and manage test ordering trends.
Mayo Clinic in collaboration with National Decision Support Company has announced a new clinical decision support tool that enables clinicians to access clinical guidance related to laboratory tests at the point of care.
The new tool has been launched when EHR vendors, hospitals, the federal government and other parties active in the healthcare industry are searching to incorporate more actionable clinical decisions support abilities into electronic health records.
Earlier this month the Clinical Decision Support Coalition also posted a guideline for planning such decision making tools. The guideline came in response to provisions mentioned in the 21st Century Cures Act especially those that move some CDS merchandises outside the United States Food and Drug Administration’s regulatory scope.
Per reports, the new CareSelect Lab software is actually a clinical decision support feature that aggregates Mayo’s healthcare knowledge about medical conditions and can easily be integrated into quality electronic health record platforms. The purpose for this is to principally deliver the best practices via NDSC’s CareSelect platform.
NDSC CEO Michael Mardini stated the new combination will allow customers to access the 1,500-plus care models which Mayo Clinic currently maintains.
Clinicians can also access CareLab for guidance on pathology, laboratory and genetic testing. They can also interact directly with the guidelines forwarded from their EHR workflow in order to access data about the right tests to order.
Per Mayo and NDSC, hospitals utilizing CareLab and CareSelect can further view analytics benchmark in order to compare practitioner’s ordering patterns and better understand the overall test trends. The analytics benchmark can also allow doctors to pinpoint gaps in care.
Mayo Department of Laboratory Medicine and Pathology chairperson William Morice said the new tools will be able to help physicians in reducing common mistakes, whether those physicians are employed at Mayo or just accessing its lab tests.
“We must extend to them the same decision guidance that we avail to our own physicians and scientists,” Morice said.
“And we must do so in a way that integrates with their current workflows and systems,” he added.
Although Mayo has not revealed the actual price of the CareLab or the CareSelect platform, the company has nonetheless disclosed a financial interest in the product and stated that it will assign the money it earns from the software for its non-profit education, patient care and research work.
